SCHEMBL9259658

SCHEMBL9259658

Cc1ccc(C2=CN3c4ccccc4SC3N2CC(N)=O)s1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 1/20 0.31
▸ LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9271818 0.90 PRNP (0.31) LMNA
SCHEMBL9569380 0.82 GSK3B (0.34) SIGMAR1LMNA
SCHEMBL9569336 0.80 BACE1 (0.36) —
SCHEMBL9569356 0.78 CACNA1C (0.39) LMNA
SCHEMBL9569373 0.78 GSK3B (0.36) LMNA
SCHEMBL9266403 0.73 KDM4E (0.33) —
SCHEMBL9569392 0.67 BCHE (0.37) —
SCHEMBL10462307 0.67 BCHE (0.32) —
SCHEMBL6936002 0.66 BCHE (0.41) SIGMAR1LMNA
SCHEMBL9271132 0.66 MYLK (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5418248-A Anticonvulsant, auxiolytic SYNTHELABO (FR) 1995-05-23 — — US disclosed
EP-0605295-A1 Derivatives of 2-thienylimidazo 2,1-b benzothiazole-3-acetic acid, their preparation and their therapeutical use SYNTHELABO (FR) 1994-07-06 — — EP disclosed
Send feedback